HK1257595A1 - 抑制胰島β細胞凋亡的藥物及其用途 - Google Patents

抑制胰島β細胞凋亡的藥物及其用途

Info

Publication number
HK1257595A1
HK1257595A1 HK18116714.1A HK18116714A HK1257595A1 HK 1257595 A1 HK1257595 A1 HK 1257595A1 HK 18116714 A HK18116714 A HK 18116714A HK 1257595 A1 HK1257595 A1 HK 1257595A1
Authority
HK
Hong Kong
Prior art keywords
drug
cell apoptosis
beta cell
pancreatic beta
inhibiting pancreatic
Prior art date
Application number
HK18116714.1A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257595A1 publication Critical patent/HK1257595A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116714.1A 2016-12-15 2018-12-28 抑制胰島β細胞凋亡的藥物及其用途 HK1257595A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162269 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257595A1 true HK1257595A1 (zh) 2019-10-25

Family

ID=62657342

Family Applications (6)

Application Number Title Priority Date Filing Date
HK18116715.0A HK1257596A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素分泌的方法
HK18116718.7A HK1257599A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素受體底物-2表達的方法
HK18116713.2A HK1257594A1 (zh) 2016-12-15 2018-12-28 一種促進胰島β細胞損傷修復和減少胰島纖維化的方法
HK18116716.9A HK1257597A1 (zh) 2016-12-15 2018-12-28 一種使胰高血糖素、胰島素恢復正常平衡的方法
HK18116712.3A HK1257593A1 (zh) 2016-12-15 2018-12-28 治療糖尿病的新藥物及其用途
HK18116714.1A HK1257595A1 (zh) 2016-12-15 2018-12-28 抑制胰島β細胞凋亡的藥物及其用途

Family Applications Before (5)

Application Number Title Priority Date Filing Date
HK18116715.0A HK1257596A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素分泌的方法
HK18116718.7A HK1257599A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素受體底物-2表達的方法
HK18116713.2A HK1257594A1 (zh) 2016-12-15 2018-12-28 一種促進胰島β細胞損傷修復和減少胰島纖維化的方法
HK18116716.9A HK1257597A1 (zh) 2016-12-15 2018-12-28 一種使胰高血糖素、胰島素恢復正常平衡的方法
HK18116712.3A HK1257593A1 (zh) 2016-12-15 2018-12-28 治療糖尿病的新藥物及其用途

Country Status (2)

Country Link
CN (7) CN108210912A (zh)
HK (6) HK1257596A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111411072B (zh) * 2020-03-09 2022-10-11 同济大学 SLC30A8基因表达下调的抗糖尿病胰岛β细胞及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
WO2003066842A2 (de) * 2002-02-06 2003-08-14 Trommsdorff Gmbh & Co. Kg Arzneimittel Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen
US9718760B2 (en) * 2012-10-31 2017-08-01 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
HK1257594A1 (zh) 2019-10-25
HK1257593A1 (zh) 2019-10-25
CN108210907A (zh) 2018-06-29
CN108210901A (zh) 2018-06-29
CN108210911A (zh) 2018-06-29
CN108210912A (zh) 2018-06-29
HK1257599A1 (zh) 2019-10-25
HK1257597A1 (zh) 2019-10-25
CN108210913A (zh) 2018-06-29
HK1257596A1 (zh) 2019-10-25
CN108339114A (zh) 2018-07-31
CN108210903A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
HK1251925A1 (zh) 物流架及其使用方法
HK1249103B (zh) 多環氨甲醯基吡啶酮化合物及其藥物用途
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
SG11202002528SA (en) Radioactive drug
IL252560A0 (en) Heterocyclic derivatives and their uses
PL3720418T3 (pl) Tabletka nikotynowa
IL254818A0 (en) Ribociclib tablet
HK1256486A1 (zh) 雙芳基衍生物和含有其的藥物
HK1232222A1 (zh) 芳雜環類衍生物及其在藥物上的應用
PT3395301T (pt) Sistema de distribuição de stent e seus conjuntos
HK1249857A1 (zh) 片劑
ZA201702901B (en) Stabilized adrenomedullin derivatives and use thereof
HK1245095A1 (zh) 依維莫司(everolimus)與達托里昔布(dactolisib)的醫藥組合
GB201416964D0 (en) Bedpan and bedpan support
LT3215143T (lt) Derinys, apimantis spiruliną ir palmitoiletanolamidą
HK1257595A1 (zh) 抑制胰島β細胞凋亡的藥物及其用途
GB201417529D0 (en) Beta lactamase inhibitors
PT3268356T (pt) Compostos heterocíclicos e métodos para a sua utilização
SI3236952T1 (sl) Farmacevtski sestavek v obliki tablet
GB2544278B (en) Syringes and inserts for syringes
GB201511252D0 (en) Tablet